Versionen im Vergleich

Schlüssel

  • Diese Zeile wurde hinzugefügt.
  • Diese Zeile wurde entfernt.
  • Formatierung wurde geändert.

Plasmid or Vector

CoV2-Spike-EF1a-D614G-N501Y

(Plasmid #177939) 

Source/Company

Usage Regulation and Limitations

View file
nameMTA_177939-CoV2-Spike-EF1a-D614G-N501Y_1568520.pdf
height250
View file
nameMTA_177939-CoV2-Spike-EF1a-D614G-N501Y_890975.pdf
height250
View file
nameAddgene UBMTA.pdf
height250

How to cite

How to cite this plasmid ( Back to top)

These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.

  • For your Materials & Methods section:
    CoV2-Spike-EF1a-D614G-N501Y was a gift from Jennifer Doudna (Addgene plasmid # 177939 ; http://n2t.net/addgene:177939 ; RRID:Addgene_177939)

  • For your References section:
    Rapid assessment of SARS-CoV-2 evolved variants using virus-like particles. Syed AM, Taha TY, Tabata T, Chen IP, Ciling A, Khalid MM, Sreekumar B, Chen PY, Hayashi JM, Soczek KM, Ott M, Doudna JA. Science. 2021 Nov 4:eabl6184. doi: 10.1126/science.abl6184 . 10.1126/science.abl6184 PubMed 34735219

Assays or Applications

VLP production

Safety information → hazardous compounds have to be added to the CLAKS

Data sheet, safety information, protocols and further information

View file
nameAddgene CoV2-Spike-EF1a-D614G-N501Y.pdf
height250

Contact information (owner) and location (plasmid or vector)

Stefanie Wedepohl/Katharina Achazi (AG Haag)

Änderungshistorie